Follow the CG인바이츠 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the authority of DART (FSS). Operating in the Health Care sector, CG인바이츠 has logged 98 reports. Market capitalisation: €73.1bn. The latest transaction was disclosed on 6 July 2026 (Other). Among the most active insiders: 뉴레이크인바이츠투자. The full history is accessible without an account.
98
Insider Decl.
0
Thresholds
€613,429
43 ops.
Buy Volume
·
24 ops.
Sell Volume
22Σ signal
Buys €613,429· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 25,622 of 26,134 companies
9.6
score / 100
Value
13
Quality
7
FCF yld-37%
Earn yld-5.1%
EV/EBITDA·
ROE·
Gross mgn-7.1%
Net mgn-13%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
CG인바이츠 is a company in the health and pharmaceutical sector, listed on the XKRX market. It specializes in developing innovative solutions for the medical field.